Long non-coding RNAs (lncRNAs) are a class of regulatory genes that participate in a wide range of biological processes, including proliferation, differentiation and development, as well as in a broad spectrum of diseases. Although the role of lncRNAs in TGF-β-induced epithelial-to-mesenchymal transition (EMT) has been well established, little is known about the role of lncRNAs as immediate-early regulators of EMT. Here lnc-Spry1 is identified as an immediate-early regulator of EMT that is downregulated by TGF-β. It is also found that knockdown of lnc-Spry1 promotes a mesenchymal-like phenotype and results in increased cell migration and invasion. In addition, it is shown that lnc-Spry1 depletion preferentially affects the expression of TGF-β-regulated gene targets. Moreover, lnc-Spry1 associates with U2AF65 splicing factor, suggesting a role in alternative splicing. Depletion of lnc-Spry1 induces, as TGF-β, isoform switching of fibroblast growth factor receptors, resulting in FGF-2-sensitive cells. Taken together, these results show that lnc-Spry1 could act as an early mediator of TGF-β signaling and reveal different roles for a lncRNA in modulating transcriptional and posttranscriptional gene expression. Cell Death and Differentiation (2017) 24, 785-797; doi:10.1038/cdd.2017.9; published online 10 February 2017
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EMT is a basic cellular process in which epithelial cells lose their epithelial characteristics and take on properties of mesenchymal cells. During EMT, epithelial cells lose their cell-cell junctions and the epithelial apical-basal polarity. The actin cytoskeleton is reorganized and cells acquire migratory and invasive properties. [1] [2] [3] This process is essential in the generation of tissues and organs during embryogenesis, during wound healing and is associated with pathologies, such as fibrosis and cancer. In carcinomas, cancer cells can undergo EMT to escape the primary tumor, invade surrounding tissues and colonize remote sites via blood or lymphatic routes generating metastases. [4] [5] [6] The EMT program can be activated efficiently and rapidly in epithelial cells in response to soluble factors or cytokines, including epidermal growth factor, fibroblast growth factors (FGFs) and transforming growth factors (TGF-βs). TGF-β may induce EMT through distinct signaling mechanisms causing substantial changes in gene expression. These changes involve three families of transcription factors: the zinc finger Snail, Zeb, and basic helix-loop-helix families. 7 Beyond the well-established transcriptional reprogramming during EMT, posttranscriptional mechanisms, such as regulation by alternative pre-mRNA splicing and regulation by noncoding RNA, have an important role and provide an additional layer of complexity on the gene regulation during EMT. [8] [9] [10] [11] [12] The mammalian genome encodes many thousands of lncRNAs, a class of transcripts 4200 nucleotides with limited protein-coding potential. 13 They can act as molecular signals, tethers, decoys, guides or scaffolds at every level of gene regulation in a wide range of biological processes. [14] [15] [16] Although transcription factors, microRNAs and signaling pathways that control EMT have been studied intensively, lncRNAs that may regulate this process in an immediate-early phase have not been identified. Several lncRNAs have been reported to be involved in EMT; [17] [18] [19] [20] [21] however, these lncRNAs have been identified in cells treated with TGF-β for days or in cells stably expressing an EMT-inducer transcription factor. Here we profiled immediate-early changes of lncRNAs in NMuMG cells following TGF-β treatment. This study reports the identification of a lncRNA located adjacent to the mouse Spry1 gene, which was named lnc-Spry1, early downregulated by TGF-β. Decreased lnc-Spry1 levels induce a mesenchymal-like phenotype leading to increased cell migration and invasion. Lnc-Spry1 was found to interact with U2AF65 RNA splicing regulator, suggesting a posttranscriptional regulation of EMT-associated genes. Taken together, our findings indicate that lnc-Spry1 modulates early transcriptional expression and alternative splicing (AS) of genes involved in the EMT process.
Results
TGF-β-mediated EMT regulates the expression of lncRNAs. Transcription factors regulating EMT are induced early. We hypothesized that lncRNAs with a differential expression during early EMT could represent putative EMT regulators. To identify such lncRNAs, transcriptional profiling was performed in untreated NMuMG mammary epithelial cells, a widely employed model to study TGF-β-induced EMT, and NMuMG cells treated with TGF-β for 2 h using chips that cover 31 Figure S1) . At this time, microarray results indicated that TGF-β treatment for 2 h led to EMT gene expression signature 22 (Supplementary Figure S1e) . Six hundred genes were found to be upregulated and 490 downregulated in treated cells compared with untreated cells, including 215 downregulated and 220 upregulated lncRNAs (Supplementary Table S1 ). Expression of several candidates was confirmed by real-time PCR. Among them, we focused on AK040898 located on mouse chromosome 3, because of its consistent early downregulation ( Figure 1a) . We termed this candidate lnc-Spry1 based on the name of the neighboring gene. Given the proximity of lnc-Spry1 to the Spry1 gene (Figure 1b) , and the fact that both are transcribed in the same orientation, we sought to ensure that the lnc-Spry1 transcript was distinct from that of the Spry1 gene. We determined by 5′ and 3′ rapid amplification of cDNA ends (RACE) that lncSpry1 is a 2851 nucleotides transcript without introns, 472 nucleotides shorter at the 5′ end than the ENCODE AK040898 transcript annotation (Figure 1c and Supplementary Figure S1 ). We next sought to detect trimethylation of histone H3 at lysine 4 (H3K4me3) enrichment at the 5′ regulatory region of lnc-Spry1. Chromatin immunoprecipitation assays showed a remarkable H3K4me3-enriched region within 800 bp of the lnc-Spry1 transcription start site, enrichment not detected in TGF-β-treated cells (Figure 1d ). These data indicate that Spry1 mRNA and lnc-Spry1 RNA are transcribed from independent promoters. Sequence analysis using ORF Finder (NCBI) predicted open reading frames o70 amino acids without a valid Kozak sequence. In addition, a low coding potential score (−0.924) and a low coding probability (0.032) returned by the Coding Potential Calculator software 23 and Coding-Potential Assessment Tool, 24 respectively, confirmed a negligible protein-coding potential for lnc-Spry1. Sequence homology searches and 5′ RACE analysis revealed no clear orthologous lnc-Spry1 sequence or transcripts in syntenic regions of the human genome, suggesting that lnc-Spry1 is a mouse-specific lncRNA. Smad4 is a central mediator of TGF-β intracellular signaling. 25 We investigated the requirement of Smad4 in lnc-Spry1 downregulation by TGF-β. Two different commercial Dicer-substrate short interfering RNAs were used for silencing Smad4 and the knockdown efficiencies were tested by western blotting. Lnc-Spry1 downregulation by TGF-β treatment was notably affected in Smad4-suppressed cells, indicating TGF-β-Smad signaling dependency of this TGF-β response (Figure 1f ). Smad-mediated signaling pathway, extracellular signal-regulated kinases (ERKs) and p38 kinases are activated very rapidly in TGF-β-treated NMuMG cells. 26 However, lnc-Spry1 downregulation appeared to uniquely rely on the Smad-mediated pathway, as preincubation of NMuMG cells with the MEK inhibitor U0126 and the p38 inhibitor SB203580 had no effect on TGF-β-downregulated lnc-Spry1 (Figures 1e and g ). Lnc-Spry1 downregulation detected within 15 min of TGF-β treatment (Figure 4b ) suggested an active role in the start of EMT program. To determine whether lnc-Spry1 was a direct target of TGF-β-Smad pathway, we analyzed the levels of lnc-Spry1 in cells treated with TGF-β in the presence or absence of cycloheximide, an inhibitor of protein synthesis. Cycloheximide treatment did not inhibit downregulation of lnc-Spry1, whereas upregulation of SIP1, an indirect target control of the TGF-β-Smad pathway, 27 was blocked ( Figure 1h ). Together, these findings strongly suggest that lnc-Spry1 is downregulated by TGF-β-Smad signaling and it is a direct target of this pathway.
Lnc-Spry1 downregulation promotes a mesenchymal-like phenotype. To investigate whether the reduced expression of lnc-Spry1 could promote the process of EMT, we generated short hairpin RNAs (shRNA)-mediated knockdown stable clones using three lnc-Spry1-targeting shRNA expression constructs. Expression of lnc-Spry1 was reduced from 60 to 70% using these different shRNAs (Figure 2a) . A consistent epithelial-to-mesenchymal-like phenotype was observed for all three shRNAs used (Figure 2b ), indicating that this change was specific and was not likely due to off-targeting. Furthermore, immunofluorescence analysis revealed a decrease in the epithelial marker E-cadherin expression and the remaining protein was dislocated from the membrane to the cytoplasm. In the absence of TGF-β, phalloidin-labeled F-actin was predominantly organized in thin cortical bundles tightly associated with cell-cell adhesions. 28 In contrast, after 48 h of treatment with TGF-β, F-actin was assembled into thick parallel bundles, or actin stress fibers, traversing the ventral cell surface. We also observed a notable remodelling of the cytoskeleton from cortical actin to stress fibers in lnc-Spry1-depleted cells Control cell data are the mean of at least n = 9 qPCR reactions from three independent experiments. Background enrichment with normal rabbit IgG was o0.05% of the total input chromatin. TGF-β-treated cell data are the mean of n = 6 qPCR reactions from two independent experiments. Background enrichment with normal rabbit IgG was o0.015% of the total input chromatin. (e) Effect of MAP kinase inhibitor, U0126, on lnc-Spry1 downregulation. NMuMG cells were pretreated with 10 μM inhibitor for 1 h prior to addition of TGF-β for 2 h where indicated. Lnc-Spry1 levels were measured by RT-qPCR (top); p-ERK1/2 were assessed by western blotting and total ERK1/2 were used as protein loading control (bottom). (f) NMuMG cells were transfected with DsiRNAs against Smad4 (DsiSmad4) or scramble DsiRNA (SRC) and treated with TGF-β for 2 h. Levels of lnc-Spry1 were measured by RT-qPCR analysis (top). Smad4 was assessed by western blotting (bottom); β-actin was used as protein loading control. (g) Effect of p38 kinase inhibitor, SB203580, on lnc-Spry1 downregulation. Cells were pretreated with 10 μM inhibitor for 1 h prior to addition of TGF-β for 2 h where indicated. Levels of lnc-Spry1 were measured by RT-qPCR analysis (top). Activation of p38 kinase was detected via phosphorylated p85 ribosomal kinase (p85). A representative immunoblot analysis for p85 is shown (bottom); β-actin was used as a protein loading control. (h) Requirement of de novo protein synthesis for lnc-Spry1 downregulation by TGF-β. NMuMG cells pretreated with 5 μM of cycloheximide (CHX) for 1 h were stimulated with TGF-β for 2 h (top) or 24 h (bottom). Expression levels of lnc-Spry1 (top) and SIP1 (bottom) were measured by RT-qPCR analysis (Figure 2c ). Immunoblotting analysis revealed a remarkable increase in the expression of mesenchymal markers, such as vimentin and Snail1, and a decrease in the expression of the epithelial marker E-cadherin in lnc-Spry1-depleted clones compared with control clones (Figure 2d ). Also RT-qPCR analysis showed that mesenchymal marker SIP1 was slightly increased in lnc-Spry1-depleted clones ( Figure 2e ). As lnc-Spry downregulation mimics TGF-β signaling in terms of EMT induction, we wondered whether lnc-Spry1 downregulation induced TGF-β expression and this could cause an autocrine TGF-β signaling. Quantification of TGF-β mRNA levels in lnc-Spry1-depleted shRNA1 and shRNA2 clonal cell lines showed that these clones contained TGF-β mRNA levels 1.4 and 2.2 times higher, respectively, than control cells. To test a possible role of autocrine TGF-β signaling in lnc-Spry1-depleted clones, we treated them with TGF-β type I receptor (ALK5) kinase inhibitor SB431542. 29 Clones were minimally affected by treatment with the inhibitor and showed mesenchymal-like phenotype (Supplementary Figure S2a) , and EMT-related molecules analyzed were not significantly affected ( Supplementary Figures S2b-e) . These results indicate that downregulation of lnc-Spry1 promotes per se a mesenchymal-like phenotype. As cell migration and invasion are altered in EMT, we assessed the migratory capacity and invasiveness of lnc-Spry1-silenced cells. Wound-healing assays revealed that shlnc-Spry1 NMuMG cells migrated much faster than control cells (Figures 3a-c and Supplementary Movie S1). Furthermore, the effect of lncSpry1 downregulation on cell invasion was determined in invasion assays in matrigel-coated transwell chambers. LncSpry1 silencing resulted in a highly significant increase in the invasive potential of NMuMG cells (Figures 3d and e) . However, monitoring of NMuMG real-time cell proliferation showed no differences between control and lnc-Spry1-depleted cells (Figure 3f ). These results demonstrate a role of lnc-Spry1 in remodeling the cell cytoskeleton and the effect of its depletion on cell migration and invasion.
Lnc-Spry1 depletion alters gene expression. LncRNAs have been shown to regulate the expression of neighboring genes in cis or in trans by diverse mechanisms. 30 The Spry1 gene is located 480 bp upstream from lnc-Spry1 and, therefore, could be a candidate to be regulated in cis. In fact, lnc-Spry1-depleted clones markedly reduced the Spry1 mRNA levels (Figure 4a ). This effect was specific for Spry1 gene, as changes were not detected in other protein-coding genes surrounding lnc-Spry1 (Supplementary Figure S3) . A detailed time course of lnc-Spry1 and Spry1 mRNA expression after TGF-β treatment for short periods of time showed a strong correlation between downregulation of both genes ( Figure 4b ). Similar to the effect of cycloheximide on lnc-Spry downregulation in TGF-β-treated cells, downregulation of Spry1 mRNA levels was not affected by cycloheximide, indicating that Spry1 is a direct target (Figure 4c ). Moreover, forced expression of lnc-Spry1 in lnc-Spry1-depleted cells did not rescue the expression of Spry1 gene (Figures 4d and e), as would be expected from a lncRNA whose primary function was exerted locally. 31 Also, overexpression of Spry1 did not lead to any noticeable morphological change in lnc-Spry1-depleted cells (Supplementary Figure S4) . To determine whether the expression of lnc-Spry1 and Spry1 genes were linked, we examined their relative expression across the same panel of different mouse tissues (Figure 4f ). Spry1 mRNA was found to be much more highly expressed than lnc-Spry1 in all the tissues analyzed. Both RNAs were more abundant in the heart, lung and muscle. Despite the variation in the expression levels of both transcripts and the different expression in the tissues analyzed, the expression profiles of Spry1 and lnc-Spry1 genes were closely correlated (Pearson correlation coefficient R = 0.98). Altogether, we might suggest that lnc-Spry1 could act locally to regulate the Spry1 expression and that they both could regulate similar biological processes. Overexpression of lnc-Spry1 did not seem to perturb normal EMT by TGF-β. Immnunofluorescence analysis of TGF-β-treated control cells and TGF-β-treated lnc-Spry1-overexpressing cells did not reveal apparent morphological changes. Also, immunoblot analysis of E-cadherin, vimentin, Snail1 and Spry1 proteins did not show any significant change in the expression levels of these proteins (Supplementary Figure S5) . This result would be consistent with the fact that EMT relies on a complex signaling network that involves multiple transcription factors and signaling proteins, in some instances, with redundant functions. As Snail1 transcription factor is a major regulator of EMT and it is a primary responder to TGF-β treatment, 32, 33 we tested whether ectopic expression of Snail1 affected the levels of lnc-Spry1 and Spry1 mRNA. Expression of both genes was unaffected by overexpression of Snail1, indicating that Snail1 is not required for lnc-Spry1 inhibition upon TGF-β treatment (Supplementary Figure S6) . We next reasoned that analysis of global gene expression pattern in lnc-Spry1-depleted cells could reveal further clues toward elucidating its function. Changes in RNA levels were analyzed by DNA microarray analysis both in stable lnc-Spry1-depleted cells and control cells. We found 181 misregulated genes in the lnc-Spry1-depleted cells (lineal change 42-fold and P-valueo0.05) among which 110 were downregulated and 71 were upregulated (Figure 4g and Supplementary  Table S2) . RT-qPCR analysis confirmed microarray results for 10 of the 12 selected genes (83%), including downregulation of Id2, Sim2, Atoh8, Cxcl5, Ccl20 and upregulation of Sox9 (Supplementary Figure S7) . Gene ontology analysis of misregulated genes in lnc-Spry1-depleted cells showed a notable enrichment in those genes involved in chemokine and cytokine activity (Ccl2, Ccl20, Ccl7, Cxcl1, Cxcl16, Bmp2, Grem1) (Figure 4h ). Strikingly, 30 and 28% of downregulated and upregulated genes, respectively, were also downregulated and upregulated in TGF-β treated Table S3 ) (P-value = 4.7 × 10 − 48 and P-value = 6.9 × 10 − 20 , hypergeometric distribution), strongly suggesting that lnc-Spry1 could participate directly and indirectly in TGF-β-dependent transcriptional response.
Lnc-Spry1 interacts with the U2AF65 spliceosome component. To investigate the mechanism by which lncSpry1 mediates gene regulation, we searched for proteins that were associated with lnc-Spry1 using in vitro biotin-RNA pull-down. In vitro-transcribed biotinylated lnc-Spry1 and a non-relevant RNA as a negative control were incubated with total cellular extracts and coprecipitated proteins were isolated using streptavidin-coated beads. RNA-associated proteins were resolved on a SDS-PAGE gel, and specific bands to the lnc-Spy1 probe were visualized using SYPRO Ruby staining and cut out for analysis by mass spectrometry (Figure 5a ), identifying U2AF65 as a protein specifically associated with lnc-Spry1 (Supplementary Figure S8) . These interactions were confirmed by western blotting analysis Lnc-Spry1 mediates EMT C Rodríguez-Mateo et al cells stimulated with TGF-β for 48 h and from 11-to 20-fold in lnc-Spry1-depleted cells, whereas FGFR2 mRNA levels decreased in both conditions (Figures 6a and b) . Using isoform-specific primers, we determined that the FGFR1 isoform upregulated by TGF-β or by lnc-Spry1 depletion was the mesenchymal isoform FGFR1IIIc (Figure 6c ), whereas (Figures 6d and e) . The different isoforms generated by this splicing event show distinct FGF-binding specificities. During TGF-β-mediated EMT, TGF-β induces isoform switching of FGFRs, sensitizing cells to FGF-2, which binds preferentially to IIIc isoforms, whereas FGF-7 and FGF-10 bind exclusively to IIIb isoforms. 34 As shown in Figure 6f , addition of FGF-2 to TGF-β-treated cells induced ERK signaling pathway, revealing isoform switching by TGF-β treatment. Interestingly, addition of FGF-2 activated ERK signaling pathway in lncSpry1-depleted cells without previous TGF-β treatment (Figure 6g ). ERK phosphorylation was not observed in Spry1-depleted cells, which showed reduced levels of FGFR1IIIc, FGFR2IIIb and FGFR2IIIc (Figure 6g and Supplementary Figures S10b-d) . Likewise, morphology of Spry1-depleted cells was not affected after FGF-2 addition (Supplementary Figure S10e) , whereas lnc-Spry1-depleted cells showed a dramatic accumulation of the actin cytoskeleton into large clamps (Figure 6h ), supporting a role for lncSpry1 in modulating the stability of actin cytoskeletal structures. Epithelial Splicing Regulatory Proteins 1 and 2 (ESRP1 and ESRP2) are key epithelial-specific RNA-binding proteins that promote splicing of the epithelial variant of the FGFR transcripts. In NMuMG cells, induction of EMT by TGF-β is accompanied by nearly complete abrogation of ESRP2 expression (ESRP1 is not expressed in NMuMG cells) and consequent isoform switching of FGFRs. 12, 35 Strikingly, depletion of lnc-Spry1 mimics the effects of TGF-β on FGFRs splicing; however, ESRP2 protein levels are not affected in lnc-Spry1-depleted cells (Supplementary Figure S9) . This fact together with the clear evidence of interaction between lnc-Spry1 and U2AF65 may suggest a redundant mechanism for FGFR isoform switching.
Discussion
The precise regulation of gene expression patterns is paramount in the transdifferentiation of epithelial cells into mesenchymal cells. 36, 37 LncRNAs have emerged as key regulatory components in different processes. 14, 16, 38, 39 Several lncRNAs have been analyzed and associated with EMT in cells upon TGF-β treatment for one or several days. 21, 40, 41 We hypothesized that lncRNAs could have an essential role as early master regulators during EMT. Here lnc-Spry1 is identified as an immediate-early gene downregulated by TGF-β with potential implications in EMT. According to ENCODE genomic annotations, 5′ end of lnc-Spry1 is 10 nucleotides away from 3′ end of Spry1 gene and both genes are located in the same DNA strand and show the same orientation, supporting the hypothesis that lnc-Spry1 could be an extension of the protein-coding Spry1 transcript. However, experiments of RACE and TGF-β-dependent enrichment of active promoter tags around the transcription start site rule out the presence of a long Spry1 isoform containing lnc-Spry1 as an extended 3′ UTR and support that Spry1 and lnc-Spry1 exist as two independent RNAs.
Signaling through TGF-β receptor complexes involves SMAD-dependent and SMAD-independent pathways. 42 In NMuMG cells stimulated with TGF-β, we found activation at short time of both ERK and p38 kinases; however, the presence of specific inhibitors of MEK and p38 MAPK kinases did not affect lnc-Spry1 downregulation. In contrast, it was notably affected in SMAD4-depleted cells. Downregulation of lnc-Spry1 was detected as early as 15 min poststimulation with TGF-β, and it was also observed in cells pretreated with cycloheximide demonstrating that it did not require de novo protein synthesis and could be categorized as an immediateearly response gene and a direct target of TGF-β-Smad pathways in NMuMG cells.
Knockdown and ectopic expression of multiple lncRNAs reveal their influence on the transcription of their neighboring protein-coding genes. 43, 44 In line with these observations, some findings suggest a local regulation of Spry1 gene by lncSpry1, such as close vicinity of Spry1 to lnc-Spry1, concurrent, rapid and de novo protein synthesis-independent downregulation of both genes in TGF-β-treated cells, downregulation of Spry1 in lnc-Spry1-depleted cells, close correlation between lnc-Spry1 and Spry1 expression in different organs and tissues and failure to rescue Spry1 expression in lncSpry1-depleted cells after forced expression of lnc-Spry1. Spry proteins are feedback regulators of receptor tyrosine kinases (RTKs) that restrain RTK-mediated ERK signaling, and therefore they have critical roles in the regulation of cell proliferation, differentiation and survival, 45, 46 and its downregulation could contribute to mesenchymal-like phenotype. 47 Analysis of the protein-coding genes in the 500 kb window surrounding the lnc-Spry1 did not reveal any transcriptional effect in the neighboring genes, except for Spry1 mRNA; interestingly, forced expression of Spry1 gene did not rescue the epithelial phenotype in lnc-Spry1-depleted cells. These observations indicated that mesenchymal-like phenotype of lnc-Spry1-depleted cells seems not to be related only to the action of lnc-Spry1 on local environment but also it could be a result of trans-mediated effects of the lnc-Spry1 transcript. In association with specific chromatin-modifying complexes, lncSpry1 could regulate in trans distantly located genes. In fact, lnc-Spry1-depleted cells showed expression changes in 181 genes, among which 30 and 28% were enriched for downregulated and upregulated genes, respectively, by TGF-β treatment. Some of them, including downregulated Id2, Sim2, Maf2 and Atoh8 or upregulated Sox9 transcription factors, could be involved in regulating specific sets of EMT-associated genes. 48, 49 Our data show that the expression of Snail1, as well as E-cadherin and vimentin markers, change significantly upon depletion of lnc-Spy1. Ectopic expression of the transcriptional repressor Snail1 50 did not affect the expression level of lnc-Spry1, indicating that lnc-Spry1 could function upstream or independently of the Snail1 signaling pathway. Interaction between lnc-Spry1 and the U2AF65 spliceosome component together with the enrichment of nuclear fraction in lnc-Spry1 suggested an active role in AS for lnc-Spry1. Recently, lncRNAs have been shown to affect AS by different mechanisms, which provides cells with an additional level of complexity to the regulation of gene expression. 38, 51, 52 Extensive changes in AS of many mRNAs have been reported in EMT. 8, 12 In the well-characterized family of FGFRs, it has been reported that FGFR1IIIc and FGFR2IIIb, respective isoforms of FGFR1 and FGFR2, are upregulated and downregulated, respectively, by TGF-β, producing NMuMG cells to be sensitive to FGF-2. 34 Lnc-Spry1-depleted cells showed upregulated FGFR1IIIc isoform and downregulated both FGFR2IIIb and FGFR2IIIc isoforms. Consistent with these changes in mRNA expression profiles of FGFR isoforms, lncSpry1-depleted cells showed actin accumulation in large clamps and ERK phosphorylation in response to FGF-2, whereas control cells treated with FGF-2 did not exhibit neither morphological changes nor ERK phosphorylation. Among the splicing factors associated with EMT, downregulation of epithelial splicing regulatory proteins (ESRPs) has been reported to promote a cell-type-specific splicing program that results in isoform switching of FGFRs. 53 Here lnc-Spry1 is shown to physically associate with the splicing factor U2AF65, and importantly, its depletion, without altering ESRP protein levels, affects isoform switching of FGFR1 and FGFR2, a similar response to that observed in TGF-β-treated cells. 8, 34, 35 Taken together, these observations support the proposal that lnc-Spry1 binding to U2AF65 may modulate its function mimicking endogenous transcripts to hijack or redistribute U2AF65 deflecting it from their primary targets. Reduced levels of lnc-Spry1 upon TGF-β treatment might reroute or alter the binding specificity of U2AF65 protein to influence its proper localization. In summary, our data reveal that lnc-Spry1 is an early TGF-β-downregulated lncRNA that acts as a key multifunctional regulator of TGF-β signaling pathways. The immediate-early downregulation of lnc-Spry1 alters the transriptional and posttranscriptional gene regulation of the epithelial cells promoting a mesechymal-like phenotype. Exploring early TGF-β-regulated lncRNAs and elucidating the function may point to new mechanisms and components of the EMT pathways as well as potential therapeutic interventions targeting EMT.
Materials and Methods
Cell culture and reagents. NMuMG cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 50 U/ml penicillin, 50 lg/ml streptomycin and 10 μg/ml insulin at 37°C in a 5% CO 2 -humidified, 95% air incubator. TGF-β was purchased from PeproTech (London, UK). SB-431542, U0126 and SB-203580 were purchased from Selleck Chemicals (Houston, TX, USA).
lncRNA microarray analysis. Total RNA was extracted from cells using TRIzol (Invitrogen, Carlsbad, CA, USA), in accordance with the manufacturer's protocol, and purified by the RNeasy Mini Kit (Qiagen, Hilden, Germany). Total RNA from each sample was quantified and quality assured by NanoDrop ND-1000 (Thermo Fisher Scientific, Waltham, MA, USA). RNA integrity was assessed by standard denaturing agarose gel electrophoresis. Samples preparation and microarray hybridization were performed based on the manufacturer's standard protocols with minor modifications. Briefly, mRNA was purified from total RNA after removal of rRNA (mRNA-ONLY Eukaryotic mRNA Isolation Kit, Epicentre, Madison, WI, USA). Then each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3′ bias using a random priming method (Arraystar Flash RNA Labeling Kit, Arraystar, Rockville, MD, USA). The labeled cRNAs were hybridized onto the Mouse LncRNA Array v2.0 (8 × 60 K, Arraystar). After having washed the slides, the arrays were scanned by the Agilent Scanner G2505C. Agilent Feature Extraction software (version 11.0.1.1) was used to analyze the acquired array images. Quantile normalization and subsequent data processing were performed using the GeneSpring GX v11.5.1 software package (Agilent Technologies, Santa Clara, CA, USA). After quantile normalization of the raw data, lncRNAs and mRNAs that at least one out of the six samples have flags in Present or Marginal ('All Targets Value') were chosen for further data analysis. The microarray contained probes for 31 423 lncRNAs that were designed by Arraystar based on the most authoritative databases (RefSeq, UCSC Known genes, Ensembl and related literature) and 25 376 coding transcripts. Each transcript is represented by a specific exon or splice junction probe, which can identify individual transcript accurately. Differentially expressed lncRNAs and mRNAs with statistical significance ((fold change) ≥ 2.0, P-value ⩽ 0.05) were identified by comparing the normalized expression levels in TGF-β-treated and untreated samples with a paired t-test.
Transfections, lentivirus production and infection assays. Transfection of NMuMG cells was performed using Viromer reagent from Lipocalyx, (Halle, Germany) following the protocol recommended by the manufacturer. Percentage of transfected cells was 490% and it was quantified by co-expression of the GFP reporter gene. Mouse Spry1 expression vector, pCMV-Sport6.1-Spry1, was obtained from the I.M.A.G.E. Consortium (Nottingham, UK) (accession number BC053428). For lentiviral production, 2.8 × 10 6 HEK293T cells were seeded onto a 10-cm Petri dish and transfected with Lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA) using 15 μg of the transfer vectors pHRSIN-DUAL or pLKO together with 10 and 5 μg of the HIV packaging plasmids pCMVDR8.91 and pVSVG, respectively. Lentiviruses were harvested 48 h posttransfection, passed through a 0.45-μm filter and concentrated by ultracentrifugation at 100 000 × g for 90 min. Virus particles were resuspended in serum-free DMEM, snap frozen in liquid nitrogen and stored at − 80°C. Titers of pHRSIN-DUAL lentiviral particles were determined by flow cytometry of NMuMG-infected cells, and titers of pLKO.1 lentiviral particles were determined by transduction of NMuMG cells and subsequent evaluation of the number of colony-forming units following puromycin selection. For generation of lnc-Spry1-downregulated cell lines (shRNAs clones), NMuMG cells were infected with pLKO-shRNA lentiviral supernatant containing 4 μg/ml polybrene and independent clones were isolated by selection in the presence of puromycin (1 μg/ml) for 2 weeks. Three independent shlnc-Spry1 sequences (shRNA1, shRNA2, shRNA3) were cloned into pLKO.1 vector and tested. Clones expressing shRNA1 gave the most effective lnc-Spry1 silencing (60% reduction of lncRNA-Spry1) and were used in most of the experiments. For ectopic expression of lnc-Spry1 or Snail1 full-length cDNAs, NMuMG cells were infected with pHRSIN-DUAL-lnc-Spry1 or pHRSIN-DUAL-Snail1 lentivirus (MOI = 2), respectively. Mouse lnc-Spry1 gene was cloned by PCR using genomic DNA of NMuMG cells. The purified amplified fragment was cloned into pHRSIN-DUAL lentivector. Primers were designed according to RACE results. Mouse Snail1 expression vector was generated from IMAGE clone 5121591 by subcloning into the same lentivector. The dual-promoter lentivector pHRSIN-DUAL (also known as pHRSIN-CSGWdINotI_pUb_Em) was kindly provided by Mary K Collins (Windeyer Institute, London, UK). Oligonucleotide sequences used for cloning are shown in Supplementary Table S4. RNA interference. RNA duplexes against Smad4 were prepared by IDT (Leuven, Belgium). DsiRNA sequences are shown in Supplementary Table S4 . Cells were transfected with RNA duplexes using Viromer reagent from Lipocalyx following the manufacturer's protocol.
Proliferation, migration and invasion assays. For growth curves, cells were harvested and transferred into 16-well E-plates, which contain electrodes integrated into the bottom surfaces of each well to measure cell index based on impedance using the xCELLigence System (Roche, Indianapolis, IN, USA). In all, 100 μl of cell culture media were first added to each well at 37°C for 30 min to equilibrate the conductors to the media. Then, 8, 4, 2 and 1 K cells were added per well, and the program was set to make readings every 30 min for 95 h. Cell migration was measured by using Culture-Inserts (IBIDI, Martinsried, Germany). The Culture-Inserts were transferred to six-well plates, and cells were seeded at a density of 7 × 10 4 /ml in each well of Culture-Inserts and cultured in phenol red-free complete medium. After 24 h of incubation, the Culture-Inserts were removed, and a 400-μm cell-free gap was created. Cell migration was observed with a Leica DMI6000 inverted microscope (Leica Microsystems, Wetzlar, Germany) equipped with a Hamamatsu ORCA-ER camera (Hamamatsu, Japan) using LEICA N PLAN 10 × , /20 × /0.25 objectives and recorded every 20 min for 23 h. Image processing was carried out using the Leica (LAS) and Adobe Photoshop (Adobe Systems, Mountain View, CA, USA) softwares. Quantification of cell surface was performed using the multiwave length cell-scoring module of the Metamorph Offline software, Molecular Devices, Sunnyvale, CA, USA and the WimScratch Wound Healing Module (WIMASIS, Munich, Germany) program. Transwell invasion assays were performed using Transwell chambers (24 well, 8 μM pore size; Cell Biolabs, San Diego, CA, USA) coated with basement membrane. Cells were allowed to grow to subconfluency and were serum-starved for 24 h. After detachment with trypsin, cells were washed with PBS, resuspended in serum-free medium and 5 × 10 4 cells were added to the upper chamber. Complete medium was added to the bottom well of the chamber. The cells that had not migrated were removed from the upper face of the filters using cotton swabs, and the cells that had migrated to the lower face of the filters were fixed with 3.7% formaldehyde, permeabilized with 100% methanol and stained with 0.05% crystal violet. Images of random fields were captured from each membrane and the number of invasive cells was counted. The mean of triplicate assays was used for each experimental condition.
Immunofluorescence microscopy. Cells grown on coverslips were fixed in 4% paraformaldehyde/phosphate-buffered saline at room temperature for 15 min and then permeabilized by incubation in 0.01% Triton X-100 in PBS. After fixation, the coverslips were blocked with 3% BSA in PBS for 45 min and incubated with primary antibody against E-cadherin (6010181, Transduction Laboratories, San José, CA, USA) for 1 h and then incubated with fluorochrome-labeled secondary antibody or phalloidin (R415, Molecular Probes, Eugene, OR, USA) for 1 h at room temperature. The coverslips were counterstained with DAPI and wide-field fluorescence imaging was performed using a Leica DM6000B microscope (Leica Microsystems). Data were processed with Adobe Photoshop CS4 (Adobe Systems).
Western blotting analysis. Protein expression was determined by immunoblotting using the following specific antibodies: polyclonal rabbit antibody against U2AF65 was purchased from Abcam (Cambridge, UK) (ab37530), monoclonal rabbit antibody against Snail1 was obtained from Cell Signaling (Danvers, MA, USA) (C15D3), monoclonal antibody against vimentin and monoclonal antibody against smad4 were acquired from Santa Cruz (Dallas, TX, USA) (sc-32322 and sc-7966), polyclonal rabbit antibody against ERK1/2 was purchased from ThermoFisher Scientific (Waltham, MA, USA) (61-7400) and polyclonal rabbit antibody against phospho-ERK1/2 and monoclonal antibody against phospho-p70 S6 kinase were purchased from Cell Signaling (#9101 and #9206). Proteins levels were normalized to β-actin (Sigma-Aldrich, St. Louis, MO, USA, A1978). Results were visualized and quantified using ChemiDoc MP Imaging system (Bio-Rad, Hercules, CA, USA). Western blotting analysis of the specific association between lnc-Spry1 and U2AF65 was normalized by measuring total protein directly on the membrane using the criterion stain-free gel imaging system (Bio-Rad).
RNA isolation, RT-qPCR and RACE. Total RNA was isolated using the TRIzol reagent according to the manufacturer's instruction (Invitrogen) and was then reverse transcribed using a mix of oligo(dT) 20 and random hexamers and SuperScript III reverse transcriptase. Reverse transcription was followed by SYBR Green quantitative PCR using iTaq Universal SYBR Green Supermix (Bio-Rad). RACE was performed using the FirstChoice RLM-RACE Kit (Ambion, Foster City, CA, USA) following the manufacturer's protocol. RT-PCR primer sequences are listed in Supplementary Table S4. RNA isolation from mouse tissues. Organs from normal C57BL/6 mice were dissected and immediately frozen in liquid nitrogen and stored at − 80°C. To isolate RNA, 40-60 mg of frozen tissue specimens were cut in small pieces and transferred to a tube containing 1 ml of TRIzol Reagent (Invitrogen). Next, they were mechanically homogenized using a Pro250 homogenizer (PROScientific, Oxford, CT, USA) and total RNA was extracted according to the manufacturer's instruction.
RNA pull-down of proteins associated with lnc-Spry1 RNA and site-directed mutagenesis. pCR2.1-Topo plasmid (Invitrogen) containing full-length and truncated lnc-Spry1 cDNAs was linearized with restriction enzyme BamH1 and purified using the DNA Clean and Concentrator-5 Kit (Zymo Research, Irvine, CA, USA). A 20-μl reaction contained 1.5 μg linearized plasmid DNA, Biotin RNA labeling mix (Roche) and 40U T7 RNA polymerase (ThermoFisher Scientifc) was incubated at 37°C for 3 h followed by RNAse-free DNAse I treatment at 37°C for 30 min. Labeled RNAs were purified using the RNeasy Mini Kit (Qiagen), checked on agarose gel and quantified. Cellular extracts were prepared resuspending 5 × 10 7 NMuMG cells in 4 ml RIP buffer (25 mM Tris-HCl pH 7.4, 150 mM KCl, 0.5 mM dithiothreitol (DTT), 0.5% NP40, 1 mM PMSF, protease inhibitor cocktail (Roche) and 20 U/ml Rnasin ribonuclease inhibitor (Promega, Madison, WI, USA) and incubated 30 min at 4°C. Extracts were homogeneized by sonication (Diagenode's Bioruptor, Diagenode, Liege, Belgium, 10 min, high power setting, 15 s on/30 s off), follwed by centrifuging for 20 min at 13 000 r.p.m. The supernatant was transferred to a new tube and precleared by applying 40 μl of equilibrated Streptavidin-coupled Dynabeads (Invitrogen) for 20 min at 4°C. In order to block binding to unspecific RNA-binding proteins, 20 μg/ml yeast RNA was added and incubated for 20 min at 4°C. Biotinylated RNA (10 pmol) was heated for 5 min at 65°C, cooled down to room temperature and next incubated with 400 μg of precleared cellular extracts and 25 μl of equilibrated streptavidin-coupled Dynabeads (Invitrogen) for 2 h at 4°C. After washing four times for 5 min with RIP buffer, proteins were denatured in SDS buffer at 95°C for 5 min and subjected to SDS-PAGE gels. Proteins were visualized by immunoblotting or by staining with SYPRO Ruby. Candidate protein bands were carefully cut out and sent out for mass spectrometric analysis. Specific mutations were produced using the QuikChange Multi Site-Directed Mutagenesis Kit (Agilent Technologies) as recommended by the manufacturer.
ChIP assays. ChIP assays were performed using anti-H3K4me3 (ab8580) from Abcam. Chromatin was sonicated to an average fragment size of 400-500 bp using the Diagenode Bioruptor. Rabbit IgG (Sigma, St. Louis, MO, USA) was used as a control for non-specific interactions. Input was prepared with 10% of the chromatin material used for immunoprecipation. Input material was diluted 1:10 before PCR amplification. Quantification of immunoprecipitated DNA was performed by real-time PCR with the Applied Biosystems 7500 real-time PCR system (Applied Biosystems, Foster City, CA), using iTaq Universal SYBR Green Supermix (BioRad). Sample quantifications by qPCR were performed in triplicate. Sequences of all oligonucleotides are provided in Supplementary Table S4. RNA immunoprecipitation. Cellular extracts were prepared from NMuMG cells crosslinked with 1% formaldehyde. Cells were resuspended in RIP buffer and incubated 30 min at 4°C and next were homogeneized by sonication (Diagenode's Bioruptor, 10 min, high power setting, 15 s on/30 s off), and centrifuged for 20 min at 13 000 r.p.m. The supernatant was preclared by applying equilibrated protein A Dynabeads (Invitrogen) and non-specific competitor tRNA. Finally, 400 μg of extracts were incubated with 4 μg of antibody against U2AF65 (Abcam) and 100 μl of protein A Dynabeads for 3 h at 4°C. Beads were washed four times for 5 min at 4°C with RIP buffer and resuspended in 100 μl of 50 mM Tris-Cl, pH 7.0, 5 mM EDTA, 10 mM DTT and 1% SDS and next were incubated at 70°C for 45 min to reverse the crosslinks. RNA was extracted using TRIzol according to the manufacturer's protocol and was reversed transcribed and subjected to PCR analysis.
Cell fractionation. The separation of nuclear and cytosolic fractions was carried out using the PARIS Kit (Life Technologies) according to the manufaturer's instructions. RNA was extracted from each fraction using TRIzol reagent (Invitrogen).
Statistical analysis. Data were analyzed by one-way ANOVA and Student's t-test comparison, using GraphPad Prism 5 (Graphpad Software, La Jolla, CA, USA). Statistical significance was reached at Po0.05.
